1. Consumption upgrades and demand increases.With the increase of national income, people pay more and more attention to health and are also willing to spend more money on health care products and medicines. This provides a broad market space for the development of pharmacies. Policy support, market standardization.
2. The reasons for more and more pharmacies are as follows: ordinary people have needs. Most people's medical model is "go to the hospital for major diseases and go to the pharmacy for minor diseases". If it's just some minor problems, many people will not choose to go to crowded hospitals, but go to pharmacies to buy some targeted drugs.
3. More and more pharmacies in China are opening, mainly because with the improvement of people's health awareness, pharmacies have become an important place for people's daily health care and disease treatment. In addition, pharmacy operators have seen the high profits of the pharmaceutical industry and the great potential of the market, so they have invested in opening pharmacies, hoping to get a share in this field.
In addition, pharmacies also have a more profitable project, that is Sell imported products. For example, some unknown imported drugs, medical devices, etc., because the price of such products is not transparent, it is relatively easier to raise the unit price and the profit is higher.
Therefore, according to the author's analysis of Chinese chain pharmacies, the most suitable profit model for Chinese chain pharmacies is the high-product profit model, because it can be applied to any pharmaceutical commercial enterprise. Only by promoting high-profit products can you increase profits. If you have a deep understanding of China's drug marketing environment, there are a lot of opportunities for high-profit products.
By selling drugs, pharmacies can complete basic business revenue, at least ensure their own pharmacy operating costs and make certain profits. The development model of health care products and drugs can fully support the operation of a pharmacy, and the profits they earn are also very obvious.
The high profit of pharmacies is an open secret, but I guess many people can't imagine how high it is. We take a certainFor example, the factory price of a box of brand cold medicine is about 5 yuan, but it can be sold for 29 yuan in pharmacies.
The profit model of self-branded products is mainly promoted by high gross profit. The next evolution is the profit model mainly based on self-branded products.
1. Yixintang is a brand of Yunnan Hongxiang Pharmaceutical Co., Ltd., which began in 1981. After 32 years of development, it has now become a large-scale joint-stock pharmaceutical enterprise group integrating traditional Chinese medicine planting, processing, Chinese and Western pharmaceutical research and development, production, wholesale, retail chain operation and medical industry.
2. It is understood that Yixintang, founded in 2000, currently has more than 2,400 chain pharmacies across the country. In Yunnan Province alone, Yixintang pharmacies have more than 1,800, forming a national large-scale pharmaceutical retail enterprise spanning Yunnan, Guizhou, Sichuan, Chongqing, Guizhou, Jin and other provinces, regions and cities, and has become a national It has the largest chain pharmacy brand of direct pharmacies.
3. Yunnan Shuanghe Pharmaceutical Co., Ltd. is a warship of Beijing Shuanghe, a pharmaceutical aircraft carrier deployed in the southwestern thear zone. It is a new type of company with the market as the core, modern medical technology as the guide, and financial support as the framework. It is a pharmaceutical professional company with a large variety of drugs in the southwest region.
4. The biggest one should be Yixintang chain bar. His family cooperates with Kunming Medical Insurance. When everyone applied for medical insurance, they were given Zhang Yixintang membership card, Khan~~.Yixintang is a pharmaceutical chain brand under Yunnan Hongxiang Pharmaceutical.
5. Ding Ding Kuaiyao Ding Ding Kuaiyao is an O2O-based medical and health Internet product. It is a third-party information display platform that assists pharmacies in providing convenient services. There are two versions, IOS and Android, and has been launched in major application markets.
HS code-based global benchmarking-APP, download it now, new users will receive a novice gift pack.
1. Consumption upgrades and demand increases.With the increase of national income, people pay more and more attention to health and are also willing to spend more money on health care products and medicines. This provides a broad market space for the development of pharmacies. Policy support, market standardization.
2. The reasons for more and more pharmacies are as follows: ordinary people have needs. Most people's medical model is "go to the hospital for major diseases and go to the pharmacy for minor diseases". If it's just some minor problems, many people will not choose to go to crowded hospitals, but go to pharmacies to buy some targeted drugs.
3. More and more pharmacies in China are opening, mainly because with the improvement of people's health awareness, pharmacies have become an important place for people's daily health care and disease treatment. In addition, pharmacy operators have seen the high profits of the pharmaceutical industry and the great potential of the market, so they have invested in opening pharmacies, hoping to get a share in this field.
In addition, pharmacies also have a more profitable project, that is Sell imported products. For example, some unknown imported drugs, medical devices, etc., because the price of such products is not transparent, it is relatively easier to raise the unit price and the profit is higher.
Therefore, according to the author's analysis of Chinese chain pharmacies, the most suitable profit model for Chinese chain pharmacies is the high-product profit model, because it can be applied to any pharmaceutical commercial enterprise. Only by promoting high-profit products can you increase profits. If you have a deep understanding of China's drug marketing environment, there are a lot of opportunities for high-profit products.
By selling drugs, pharmacies can complete basic business revenue, at least ensure their own pharmacy operating costs and make certain profits. The development model of health care products and drugs can fully support the operation of a pharmacy, and the profits they earn are also very obvious.
The high profit of pharmacies is an open secret, but I guess many people can't imagine how high it is. We take a certainFor example, the factory price of a box of brand cold medicine is about 5 yuan, but it can be sold for 29 yuan in pharmacies.
The profit model of self-branded products is mainly promoted by high gross profit. The next evolution is the profit model mainly based on self-branded products.
1. Yixintang is a brand of Yunnan Hongxiang Pharmaceutical Co., Ltd., which began in 1981. After 32 years of development, it has now become a large-scale joint-stock pharmaceutical enterprise group integrating traditional Chinese medicine planting, processing, Chinese and Western pharmaceutical research and development, production, wholesale, retail chain operation and medical industry.
2. It is understood that Yixintang, founded in 2000, currently has more than 2,400 chain pharmacies across the country. In Yunnan Province alone, Yixintang pharmacies have more than 1,800, forming a national large-scale pharmaceutical retail enterprise spanning Yunnan, Guizhou, Sichuan, Chongqing, Guizhou, Jin and other provinces, regions and cities, and has become a national It has the largest chain pharmacy brand of direct pharmacies.
3. Yunnan Shuanghe Pharmaceutical Co., Ltd. is a warship of Beijing Shuanghe, a pharmaceutical aircraft carrier deployed in the southwestern thear zone. It is a new type of company with the market as the core, modern medical technology as the guide, and financial support as the framework. It is a pharmaceutical professional company with a large variety of drugs in the southwest region.
4. The biggest one should be Yixintang chain bar. His family cooperates with Kunming Medical Insurance. When everyone applied for medical insurance, they were given Zhang Yixintang membership card, Khan~~.Yixintang is a pharmaceutical chain brand under Yunnan Hongxiang Pharmaceutical.
5. Ding Ding Kuaiyao Ding Ding Kuaiyao is an O2O-based medical and health Internet product. It is a third-party information display platform that assists pharmacies in providing convenient services. There are two versions, IOS and Android, and has been launched in major application markets.
Optimizing distribution using HS code data
author: 2024-12-24 02:01Trade data-driven transport mode selection
author: 2024-12-24 01:25Construction materials HS code references
author: 2024-12-23 23:48Australia import export data visualization
author: 2024-12-23 23:41Marble and granite HS code references
author: 2024-12-23 23:37Leather goods HS code classification
author: 2024-12-24 01:48How to use HS codes for tariff predictions
author: 2024-12-24 01:47HS code-driven tariff equalization
author: 2024-12-24 00:30HS code-based compliance checks for EU
author: 2024-12-24 00:05Refined metals HS code references
author: 2024-12-23 23:54386.37MB
Check673.49MB
Check981.21MB
Check672.95MB
Check984.66MB
Check298.92MB
Check285.69MB
Check415.17MB
Check644.73MB
Check994.95MB
Check365.53MB
Check416.83MB
Check736.23MB
Check711.62MB
Check119.21MB
Check825.43MB
Check292.24MB
Check746.39MB
Check727.33MB
Check814.29MB
Check124.78MB
Check412.71MB
Check273.12MB
Check694.25MB
Check675.66MB
Check822.36MB
Check939.16MB
Check669.33MB
Check369.17MB
Check589.86MB
Check946.46MB
Check452.63MB
Check493.65MB
Check675.98MB
Check665.35MB
Check541.97MB
CheckScan to install
HS code-based global benchmarking to discover more
Netizen comments More
1429 Petroleum products HS code insights
2024-12-24 01:26 recommend
943 Data-driven multimodal transport decisions
2024-12-24 01:11 recommend
814 Comprehensive customs ruling database
2024-12-24 01:04 recommend
2620 Global trade intelligence for banking
2024-12-24 00:17 recommend
158 Cost-benefit analysis of export markets
2024-12-24 00:06 recommend